Scott T. Rottinghaus, Chief Medical Officer: Enanta Pharmaceuticals ENTA Sell · Filed 24/07/15

Trade details

Type: Insider sale
Amount: $34,155.84
Shares · price: 2,271 sh · $15.04 a share
Held after: 21,717 sh
Stock: Enanta Pharmaceuticals ENTA
Person: Scott T. RottinghausChief Medical Officer
Trade date: 24/07/12
Filed: 24/07/15
Days to filing: 3 days

Sold 9.5% of holdings

Share of holding sold: 9.5%

Enanta Pharmaceuticals trades, last 26 weeks

What else happened in Enanta Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/06/12~24/08/11

Scott T. Rottinghaus's recent trades

Scott T. RottinghausChief Medical Officer
SellEnanta Pharmaceuticals
Sell
Enanta Pharmaceuticals
ENTA
$11.4K
798 sh
$11.4K
Filed 25/12/05
Traded 25/12/05
Scott T. RottinghausChief Medical Officer
Sell10b5-1 planEnanta Pharmaceuticals
Sell10b5-1 plan
Enanta Pharmaceuticals
ENTA
$6,980
866 sh
$6,980
Filed 24/12/10
Traded 24/12/06
Scott T. RottinghausChief Medical Officer
Sell10b5-1 planEnanta Pharmaceuticals
Sell10b5-1 plan
Enanta Pharmaceuticals
ENTA
$91.8K
5,375 sh
$91.8K
Filed 24/07/15
Traded 24/07/15
Scott T. RottinghausChief Medical Officer
Sell10b5-1 planEnanta Pharmaceuticals
Sell10b5-1 plan
Enanta Pharmaceuticals
ENTA
$64.8K
4,299 sh
$64.8K
Filed 24/07/15
Traded 24/07/11
Scott T. RottinghausSr. VP & CMO
SellEnanta Pharmaceuticals
Sell
Enanta Pharmaceuticals
ENTA
$5,142
534 sh
$5,142
Filed 23/12/06
Traded 23/12/05